{"owner": "ArrayExpress Uploader", "pop_total": 0, "species": "human", "factors": [{"GSM1111662": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 69, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "male"}}, {"GSM1111663": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 59, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "male"}}, {"GSM1111664": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 50, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "female"}}, {"GSM1111665": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 65, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "male"}}, {"GSM1111662": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 69, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "male"}}, {"GSM1111667": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 53, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "female"}}, {"GSM1111668": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 65, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "female"}}, {"GSM1111669": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 49, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "male"}}, {"GSM1111670": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 65, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "male"}}, {"GSM111167": {"PATHOLOGICAL RESPONSE TO CRP": NaN, "AGE": 63, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "normal esophageal epithelium", "SEX": "male"}}, {"GSM1111672": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 61, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111673": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 43, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111674": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 59, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111675": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 50, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111674": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 59, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111677": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 55, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111678": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 54, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111679": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 53, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111680": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 57, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "female"}}, {"GSM111168": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 53, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111682": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 60, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111683": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 54, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111683": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 54, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111685": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 69, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111679": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 53, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111679": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 53, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111674": {"PATHOLOGICAL RESPONSE TO CRP": "not pathological complete response", "AGE": 59, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111689": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 62, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111690": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 48, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM111169": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 56, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "female"}}, {"GSM1111692": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 49, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111693": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 59, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "female"}}, {"GSM1111694": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 46, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111695": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 64, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111696": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 59, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111697": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 65, "TUMOR STAGE": "T3N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111698": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 63, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}, {"GSM1111699": {"PATHOLOGICAL RESPONSE TO CRP": "pathological complete response", "AGE": 61, "TUMOR STAGE": "T2N1M0", "ORGANISM PART": "esophageal squamous cell carcinoma (ESCC)", "SEX": "male"}}], "id": 4641, "ownerprofile_id": "arrayexpress_sid", "platform": 4, "summary_wrapped": "Preoperative chemoradiotherapy (CRT)  followed by surgery has been proved to improve esophageal squamous cell carcinoma (ESCC) patients\u2019...", "geo_gse_id": "E-GEOD-45670", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 5, "sample_count": 38, "tags": ["cancer", "carcinoma", "cell", "squamous", "squamous cell", "squamous cell carcinoma"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_id_plat": "E-GEOD-45670_A-AFFY-44", "slug": "expression-data-from-esophageal-squamous-cell-ca-2", "geo_gds_id": "", "name": "Expression data from esophageal squamous cell carcinomas and normal esophageal epithelia", "created": "Sep.21, 2014", "summary": "Preoperative chemoradiotherapy (CRT)  followed by surgery has been proved to improve esophageal squamous cell carcinoma (ESCC) patients\u2019 survival in comparison with surgery alone. However, the outcomes of CRT are heterogeneous, and no clinical or pathological method could predict CRT response. We aim to identify mRNA markers for ESCC CRT-response prediction through gene expression analyses. Gene expression analyses were performed on pretreatment cancer biopsies from 28 ESCCs who received neoadjuvant CRT and surgery and 10 normal esophageal epithelia using Affymetrix U133 Plus 2.0 arrays.", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-45670", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-45670/samples/"}